Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12287-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- CIDEC antibody
- Antibody type
- Polyclonal
- Description
- CIDEC antibody (Cat. #12287-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Gallic acid mitigates high-fat and high-carbohydrate diet-induced steatohepatitis by modulating the IRF6/PPARγ signaling pathway.
RNF180 suppressed aggressiveness by degrading NOTCH1, TRIM24 and FOXC1, and chemoresistance by degrading ACC1 and ACLY in colorectal cancer.
Shift work promotes adipogenesis via cortisol-dependent downregulation of EGR3-HDAC6 pathway.
Fisetin Ameliorates Hepatocyte Lipid Droplet Accumulation via Targeting the Rhythmic Protein BMAL1 to Regulate Cell Death-Inducing DNA Fragmentation Factor-α-like Effector C-Mediated Lipid Droplet Fusion.
The facilitating effects of KRT80 on chemoresistance, lipogenesis, and invasion of esophageal cancer.
Identification of potential pathogenic hepatic super-enhancers regulatory network in high-fat diet induced hyperlipidemia.
Long-term NAD+ supplementation prevents the progression of age-related hearing loss in mice.
Glutathione S-transferase Mu 2 inhibits hepatic steatosis via ASK1 suppression.
Dihydroartemisinin inhibits ER stress-mediated mitochondrial pathway to attenuate hepatocyte lipoapoptosis via blocking the activation of the PI3K/Akt pathway.
Qiu J, Fu L, Xue Y, Yang Y, Qiao F, Zhu W, Gao Y, Fang M, Liu Y, Gao Z, Guan Y, Gao Y, Zhang X, Shang Z
Frontiers in pharmacology 2025;16:1563561
Frontiers in pharmacology 2025;16:1563561
RNF180 suppressed aggressiveness by degrading NOTCH1, TRIM24 and FOXC1, and chemoresistance by degrading ACC1 and ACLY in colorectal cancer.
Li N, Zhang R, Zhao XX, Zhou L, Li YL, Cui ZG, Zheng HC
International immunopharmacology 2025 Nov 14;165:115445
International immunopharmacology 2025 Nov 14;165:115445
Shift work promotes adipogenesis via cortisol-dependent downregulation of EGR3-HDAC6 pathway.
Wan X, Wang L, Khan MA, Peng L, Zhang K, Sun X, Yi X, Wang Z, Chen K
Cell death discovery 2024 Mar 11;10(1):129
Cell death discovery 2024 Mar 11;10(1):129
Fisetin Ameliorates Hepatocyte Lipid Droplet Accumulation via Targeting the Rhythmic Protein BMAL1 to Regulate Cell Death-Inducing DNA Fragmentation Factor-α-like Effector C-Mediated Lipid Droplet Fusion.
Zhang R, Liu M, Lu J, Lu S, Wang Y, Guan S
Journal of agricultural and food chemistry 2024 Dec 4;72(48):26884-26897
Journal of agricultural and food chemistry 2024 Dec 4;72(48):26884-26897
The facilitating effects of KRT80 on chemoresistance, lipogenesis, and invasion of esophageal cancer.
Yun WJ, Li J, Yin NC, Zhang CY, Cui ZG, Zhang L, Zheng HC
Cancer biology & therapy 2024 Dec 31;25(1):2302162
Cancer biology & therapy 2024 Dec 31;25(1):2302162
Identification of potential pathogenic hepatic super-enhancers regulatory network in high-fat diet induced hyperlipidemia.
Hu Y, Xu R, Feng J, Zhang Q, Zhang L, Li Y, Sun X, Gao J, Chen X, Du M, Chen Z, Liu X, Fan Y, Zhang Y
The Journal of nutritional biochemistry 2024 Apr;126:109584
The Journal of nutritional biochemistry 2024 Apr;126:109584
Long-term NAD+ supplementation prevents the progression of age-related hearing loss in mice.
Okur MN, Sahbaz BD, Kimura R, Manor U, Patel J, Park JH, Andrade L, Puligilla C, Croteau DL, Bohr VA
Aging cell 2023 Sep;22(9):e13909
Aging cell 2023 Sep;22(9):e13909
Glutathione S-transferase Mu 2 inhibits hepatic steatosis via ASK1 suppression.
Jin Y, Tan Y, Zhao P, Guo Y, Chen S, Wu J, Ren Z
Communications biology 2022 Apr 6;5(1):326
Communications biology 2022 Apr 6;5(1):326
Dihydroartemisinin inhibits ER stress-mediated mitochondrial pathway to attenuate hepatocyte lipoapoptosis via blocking the activation of the PI3K/Akt pathway.
Chen X, Bian M, Zhang C, Kai J, Yao Z, Jin H, Lu C, Shao J, Chen A, Zhang F, Zheng S
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2018 Jan;97:975-984
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2018 Jan;97:975-984
No comments: Submit comment
No validations: Submit validation data